Methods for selection and stimulation of cells and apparatus for same
AssigneeC3S2 GmbH
InventorsLothar Germeroth, Christian Stemberger, Mateusz Pawel Poltorak, Thomas Schmidt
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for selecting and stimulating a plurality of cells in a sample of cells using column chromatography, and collecting the cells without using additional steps or reagents to facilitate detachment of the cells from the column. In some aspects, the methods provided herein reduce the time needed to generate a population of selected and stimulated cells useful for genetic engineering, and ultimately, cell therapy, compared to existing methods. Also provided are articles of manufacture and apparatus thereof.
Claims39
A method of on-column stimulation of T cells, the method comprising:
- (a) adding an oligomeric stimulatory reagent capable of delivering a stimulatory signal in T cells to a stationary phase comprising a plurality of T cells immobilized on the stationary phase, thereby initiating incubation of the stimulatory reagent with one or more T cells, wherein:
- the stationary phase is comprised in a chromatography column and comprises a selection agent that specifically binds to a selection marker on the surface of one or more T cells or a subset thereof, wherein specific binding of the selection agent to the selection marker expressed by the one or more T cells immobilizes the one or more T cells on the stationary phase;
- and
- the oligomeric stimulatory reagent comprises one or more stimulatory agents comprising (i) a first stimulatory agent that is an anti-CD3 antibody, and (ii) a second stimulatory agent that is an anti-CD28 antibody;
- and
- (b) within 24 hours of initiating incubation, collecting one or more of the plurality of T cells detached from the stationary phase by downregulation of the selection marker and by gravity flow without the addition of a competition agent or free binding agent to elute the plurality of T cells from the stationary phase, thereby generating a composition comprising stimulated T cells.
A method of on-column stimulation of T cells, the method comprising:
- (a) incubating a plurality of T cells immobilized on a stationary phase with one or more stimulatory agents to deliver a stimulatory signal in one or more T cells of the plurality of T cells, said stationary phase comprised in a chromatography column and comprising a selection agent that specifically binds to a selection marker on the surface of the one or more T cells, wherein specific binding of the selection agent to the selection marker expressed by the one or more T cells immobilizes the one or more T cells on the stationary phase;
- and
- (b) within 24 hours of the initiation of the incubation, collecting the one or more T cells detached from the stationary phase by downregulation of the selection marker and by gravity flow without the addition of a competition agent or free binding agent to elute the plurality of T cells from the stationary phase, thereby generating a composition comprising stimulated T cells.
A method of on-column stimulation of T cells, the method comprising:
- (a) adding a sample comprising a plurality of T cells to a stationary phase comprised in a chromatography column, said stationary phase comprising a selection agent that binds to a selection marker on the surface of one or more of the plurality of T cells, thereby immobilizing the one or more of the plurality of T cells on the stationary phase;
- (b) adding, to the stationary phase, a stimulatory reagent comprising one or more stimulatory agents capable of delivering a stimulatory signal in one or more of said plurality of T cells, thereby initiating incubation of the stimulatory reagent with the one or more of said plurality of T cells;
- and
- (c) within 24 hours of the initiating incubation, collecting one or more of said plurality of T cells detached from the stationary phase by downregulation of the selection marker and by gravity flow without the addition of a competition agent or free binding agent to elute the plurality of T cells from the stationary phase, thereby generating a composition comprising stimulated T cells.
A method of on-column stimulation of T cells, comprising:
- (a) combining (i) a sample comprising a plurality of T cells and (ii) a stationary phase comprised in a chromatography column and comprising a selection agent capable of specifically binding to a selection marker expressed on the surface of one or more of the plurality of T cells, wherein specific binding of the selection agent to a selection marker immobilizes said one or more of the plurality of T cells on the stationary phase;
- (b) adding, to the stationary phase, a stimulatory reagent comprising one or more stimulatory agents capable of delivering a stimulatory signal in T cells, thereby initiating incubation of the stimulatory reagent with the one or more of the plurality of T cells;
- and
- (c) within 24 hours of the initiating incubation, collecting one or more of said plurality of T cells detached from the stationary phase by downregulation of the selection marker and by gravity flow without the addition of a competition agent or free binding agent to elute the plurality of T cells from the stationary phase, thereby generating a composition comprising stimulated T cells.
A method of on-column stimulation of T cells, the method comprising adding an oligomeric stimulatory reagent to a stationary phase comprising a plurality of T cells immobilized on the stationary phase, thereby initiating incubation of the stimulatory reagent with one or more T cells of the plurality of T cells, wherein:
- the stationary phase is comprised in a chromatography column and comprises a selection agent that specifically binds to a selection marker on the surface of one or more T cells, wherein specific binding of the selection agent to the selection marker expressed by the one or more T cells immobilizes said one or more T cells on the stationary phase;
- and
- the oligomeric stimulatory reagent comprises (i) a plurality of streptavidin or streptavidin mutein molecules and (ii) one or more stimulatory agents capable of delivering a stimulatory signal in one or more T cells, wherein the size of the oligomeric stimulatory reagent comprises (i) a radius of greater than 50 nm, (ii) a molecular weight of at least 5×106 g/mol;
- and/or (iii) at least 100 streptavidin or streptavidin mutein tetramers;
- and
- within 24 hours of the initiating incubation, collecting one or more of the plurality of T cells detached from the stationary phase by downregulation of the selection marker and by gravity flow without the addition of a competition agent or free binding agent to elute the plurality of T cells from the stationary phase, thereby generating a composition containing stimulated T cells.
A method of on-column stimulation of T cells, the method comprising:
- (a) adding an oligomeric stimulatory reagent capable of delivering a stimulatory signal in T cells to a stationary phase comprising a plurality of T cells immobilized on the stationary phase, thereby initiating incubation of the stimulatory reagent with one or more T cells, wherein:
- the stationary phase is comprised in a chromatography column and comprises a selection agent capable of specifically binding to a selection marker on the surface of one or more T cells or a subset thereof, wherein specific binding of the selection agent to a selection marker expressed by the one or more T cells or a subset thereof immobilizes said plurality of T cells on the stationary phase, and wherein the selection agent is a Fab fragment capable of specifically binding to a selection marker selected from the group consisting of CD3, CD4, and CD8;
- and
- the oligomeric stimulatory reagent comprises (i) a plurality of streptavidin mutein molecules, (ii) a first stimulatory agent capable of delivering a stimulatory signal in one or more T cells, wherein the first stimulatory agent is a Fab fragment capable of specifically binding to CD3, and (iii) a second stimulatory agent capable of enhancing, dampening, or modifying the stimulatory signal, wherein the second stimulatory agent is a Fab fragment capable of specifically binding to CD28, and wherein the size of the oligomeric stimulatory reagent comprises (i) a radius of greater than 50 nm, (ii) a molecular weight of at least 5×106 g/mol;
- and/or (iii) at least 100 streptavidin or streptavidin mutein tetramers;
- and
- (b) within 24 hours of initiating incubation, collecting one or more of the plurality of T cells detached from the stationary phase by downregulation of the selection marker and by gravity flow without the addition of a competition agent or free binding agent to elute the plurality of T cells from the stationary phase.
Dependencies are inferred from the claim text.